Media headlines about Taro Pharmaceutical Industries (NYSE:TARO) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Taro Pharmaceutical Industries earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave media coverage about the company an impact score of 45.9241501437486 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Taro Pharmaceutical Industries (TARO) opened at 105.42 on Friday. The stock’s 50 day moving average is $108.15 and its 200-day moving average is $112.51. Taro Pharmaceutical Industries has a 1-year low of $92.28 and a 1-year high of $127.57. The firm has a market capitalization of $4.27 billion, a PE ratio of 10.74 and a beta of 0.66.

A number of equities analysts have recently weighed in on TARO shares. TheStreet raised shares of Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a research note on Thursday, July 20th. BidaskClub cut shares of Taro Pharmaceutical Industries from a “hold” rating to a “sell” rating in a research note on Friday, August 11th. Finally, Credit Suisse Group cut shares of Taro Pharmaceutical Industries from an “outperform” rating to a “neutral” rating in a research note on Tuesday, May 23rd.

COPYRIGHT VIOLATION WARNING: “Taro Pharmaceutical Industries (TARO) Receiving Somewhat Favorable Media Coverage, Accern Reports” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Insider Buying and Selling by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with's FREE daily email newsletter.